HUP9601524A3 - Prodrugs of paclytaxel-derivatives - Google Patents

Prodrugs of paclytaxel-derivatives

Info

Publication number: HUP9601524A3
Authority: HU; Hungary
Prior art keywords: paclytaxel; prodrugs; derivatives
Prior art date: 1995-06-06

Application number

HU9601524A

Other languages

English (en)

Original Assignee

Bristol Myers Squibb Company P

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-06

Filing date

1996-06-05

Publication date

2000-03-28

1996-06-05 Application filed by Bristol Myers Squibb Company P filed Critical Bristol Myers Squibb Company P

1996-07-29 Publication of HU9601524D0 publication Critical patent/HU9601524D0/hu

1997-05-28 Publication of HUP9601524A2 publication Critical patent/HUP9601524A2/hu

2000-03-28 Publication of HUP9601524A3 publication Critical patent/HUP9601524A3/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
- C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HU9601524A 1995-06-06 1996-06-05 Prodrugs of paclytaxel-derivatives HUP9601524A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US46924795A	1995-06-06	1995-06-06

Publications (3)

Publication Number	Publication Date
HU9601524D0 HU9601524D0 (en)	1996-07-29
HUP9601524A2 HUP9601524A2 (en)	1997-05-28
HUP9601524A3 true HUP9601524A3 (en)	2000-03-28

Family

ID=23863053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9601524A HUP9601524A3 (en)	1995-06-06	1996-06-05	Prodrugs of paclytaxel-derivatives

Country Status (23)

Country	Link
EP (1)	EP0747385B1 (hu)
JP (1)	JPH08337589A (hu)
KR (1)	KR100375956B1 (hu)
CN (1)	CN1066151C (hu)
AR (1)	AR002756A1 (hu)
AT (1)	ATE222259T1 (hu)
AU (1)	AU695959B2 (hu)
CA (1)	CA2176191A1 (hu)
CZ (1)	CZ291516B6 (hu)
DE (1)	DE69622933T2 (hu)
DK (1)	DK0747385T3 (hu)
ES (1)	ES2181824T3 (hu)
HU (1)	HUP9601524A3 (hu)
IL (1)	IL118526A (hu)
MX (1)	MX9601994A (hu)
NO (1)	NO315233B1 (hu)
NZ (1)	NZ286723A (hu)
PL (1)	PL187883B1 (hu)
PT (1)	PT747385E (hu)
RU (1)	RU2162082C2 (hu)
SG (1)	SG72692A1 (hu)
TW (1)	TW354293B (hu)
ZA (1)	ZA964261B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6395770B1 (en) *	1995-10-26	2002-05-28	Baker Norton Pharmaceuticals, Inc.	Method and compositions for administering taxanes orally to human patients
US6515016B2 (en)	1996-12-02	2003-02-04	Angiotech Pharmaceuticals, Inc.	Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en)	1996-12-02	2002-12-17	Angiotech Pharmaceuticals, Inc.	Method for treating multiple sclerosis
CN1261275A (zh) *	1997-05-27	2000-07-26	巴克·诺顿药物有限公司	给予病人口服紫杉烷类药物的方法和组合物
US6204257B1 (en)	1998-08-07	2001-03-20	Universtiy Of Kansas	Water soluble prodrugs of hindered alcohols
US6538038B1 (en) *	1999-02-18	2003-03-25	Oxigene, Inc.	Compositions and methods for use in targeting vascular destruction
US6362172B2 (en) *	2000-01-20	2002-03-26	Bristol-Myers Squibb Company	Water soluble prodrugs of azole compounds
PL350315A1 (en)	2000-02-02	2002-12-02	Univ Florida State Res Found	C7 carbonate substituted taxanes as antitumor agents
CO5280224A1 (es)	2000-02-02	2003-05-30	Univ Florida State Res Found	Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
US6916942B2 (en)	2000-02-03	2005-07-12	Bristol-Myers Squibb Company	Process for the preparation of C-4 carbonate taxanes
US6750246B1 (en)	2000-02-03	2004-06-15	Bristol-Myers Squibb Company	C-4 carbonate taxanes
US7063977B2 (en)	2001-08-21	2006-06-20	Bristol-Myers Squibb Company	Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) *	2001-12-13	2003-06-25	주식회사 코오롱	방사선 감작제용 파클리탁셀 유도체
SV2006002036A (es)	2004-03-05	2006-03-16	Univ Florida State Res Found	Taxanos con sustituyente lactiloxilo en el c7
EP2896412A1 (en) *	2005-02-18	2015-07-22	Abraxis BioScience, LLC	Drugs with improved hydrophobicity for incorporation in medical devices
EP3492470A1 (en)	2013-03-15	2019-06-05	Concert Pharmaceuticals, Inc.	Deuterated palbociclib with improved metabolic stability
WO2015009889A1 (en)	2013-07-18	2015-01-22	Concert Pharmaceuticals, Inc.	Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
WO2017087594A1 (en) *	2015-11-19	2017-05-26	Biohaven Pharmaceutical Holding Company Ltd.	Amine prodrugs of pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2111527C (en) *	1992-12-24	2000-07-18	Jerzy Golik	Phosphonooxymethyl ethers of taxane derivatives
CA2129288C (en) *	1993-08-17	2000-05-16	Jerzy Golik	Phosphonooxymethyl esters of taxane derivatives

1996
- 1996-04-27 TW TW085105043A patent/TW354293B/zh active
- 1996-05-09 CA CA002176191A patent/CA2176191A1/en not_active Abandoned
- 1996-05-27 ZA ZA9604261A patent/ZA964261B/xx unknown
- 1996-05-27 MX MX9601994A patent/MX9601994A/es not_active IP Right Cessation
- 1996-05-29 CZ CZ19961563A patent/CZ291516B6/cs not_active IP Right Cessation
- 1996-05-31 NO NO19962231A patent/NO315233B1/no not_active Application Discontinuation
- 1996-06-02 IL IL11852696A patent/IL118526A/en not_active IP Right Cessation
- 1996-06-03 AR ARP960102865A patent/AR002756A1/es active IP Right Grant
- 1996-06-03 JP JP8139795A patent/JPH08337589A/ja active Pending
- 1996-06-04 KR KR1019960019825A patent/KR100375956B1/ko not_active IP Right Cessation
- 1996-06-04 NZ NZ286723A patent/NZ286723A/en unknown
- 1996-06-05 ES ES96109044T patent/ES2181824T3/es not_active Expired - Lifetime
- 1996-06-05 PL PL31463796A patent/PL187883B1/pl not_active IP Right Cessation
- 1996-06-05 EP EP96109044A patent/EP0747385B1/en not_active Expired - Lifetime
- 1996-06-05 PT PT96109044T patent/PT747385E/pt unknown
- 1996-06-05 AT AT96109044T patent/ATE222259T1/de not_active IP Right Cessation
- 1996-06-05 AU AU54718/96A patent/AU695959B2/en not_active Ceased
- 1996-06-05 DE DE69622933T patent/DE69622933T2/de not_active Expired - Fee Related
- 1996-06-05 HU HU9601524A patent/HUP9601524A3/hu unknown
- 1996-06-05 RU RU96111012/04A patent/RU2162082C2/ru not_active IP Right Cessation
- 1996-06-05 DK DK96109044T patent/DK0747385T3/da active
- 1996-06-06 SG SG1996009989A patent/SG72692A1/en unknown
- 1996-06-06 CN CN96106851A patent/CN1066151C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AR002756A1 (es)	1998-04-29
NZ286723A (en)	1998-03-25
IL118526A (en)	2001-05-20
IL118526A0 (en)	1996-10-16
DK0747385T3 (da)	2002-12-16
PT747385E (pt)	2002-11-29
HUP9601524A2 (en)	1997-05-28
ZA964261B (en)	1997-11-27
PL187883B1 (pl)	2004-10-29
ES2181824T3 (es)	2003-03-01
DE69622933D1 (de)	2002-09-19
AU5471896A (en)	1996-12-19
NO962231D0 (no)	1996-05-31
CA2176191A1 (en)	1996-12-07
CN1066151C (zh)	2001-05-23
NO962231L (no)	1996-12-09
KR100375956B1 (ko)	2003-04-21
TW354293B (en)	1999-03-11
CZ291516B6 (cs)	2003-03-12
NO315233B1 (no)	2003-08-04
MX9601994A (es)	1997-08-30
KR970000222A (ko)	1997-01-21
AU695959B2 (en)	1998-08-27
HU9601524D0 (en)	1996-07-29
EP0747385B1 (en)	2002-08-14
PL314637A1 (en)	1996-12-09
SG72692A1 (en)	2000-05-23
DE69622933T2 (de)	2003-04-24
CZ156396A3 (en)	1996-12-11
EP0747385A1 (en)	1996-12-11
CN1144805A (zh)	1997-03-12
ATE222259T1 (de)	2002-08-15
JPH08337589A (ja)	1996-12-24
RU2162082C2 (ru)	2001-01-20

Publication	Publication Date	Title
PL322277A1 (en)	1998-01-19	Derivatives of pyrazol-4-ylobenzoyl
GB9526560D0 (en)	1996-02-28	Use of 2-Amino-Heterocycles
PL324451A1 (en)	1998-05-25	Derivatives of diphenylmethylenepiperidine
HUP9601524A3 (en)	2000-03-28	Prodrugs of paclytaxel-derivatives
SG42329A1 (en)	1997-08-15	Use of phenylcyclohexylcarboxamides
GB9602717D0 (en)	1996-04-10	Dartboards
GB2305006B (en)	1999-04-28	Manufacture of switchgear
PL323148A1 (en)	1998-03-16	Esters of crabapenemes
GB9526273D0 (en)	1996-02-21	New prodrugs
PL323141A1 (en)	1998-03-16	Esters of crabapenemes
SG64924A1 (en)	1999-05-25	Inhibiting photodecompostion of 3-substituted-2- oxindoles
ZA962440B (en)	1996-10-01	Destressing of railtracks
GB9503734D0 (en)	1995-04-12	Manufacture of polyanlines
AU129378S (en)	1997-03-10	TeleChipper
GB9500344D0 (en)	1995-03-01	Softicks
PL311976A1 (en)	1996-06-24	Closed-profile shape of double-o type
IL115554A0 (en)	1996-01-19	Earthquake-proofing of structures
HRP950468A2 (en)	1998-04-30	New medicine - combination of components
GB9502747D0 (en)	1995-03-29	Insulants
HU9503668D0 (en)	1996-03-28	Attaching means of hooses
GB9512234D0 (en)	1995-08-16	Icositetrahedron shaped part
GB9510771D0 (en)	1995-07-19	Mask mate
AU125852S (en)	1996-02-13	Tea - towel
AU130380S (en)	1997-06-23	Matting-tile
AU128041S (en)	1996-09-16	Gamesboard